J. Teishima, “Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors”, CUAJ, vol. 14, no. 11, pp. E582–7, Jun. 2020.